Bank of America is looking at both pharmaceuticals and wind power. The bank issues buy recommendations for AstraZeneca and Nordex, citing valuations that are considered too attractive to ignore. The cases differ, but the conclusion is the same: Bank of America sees a buy position in both companies. FDA announcement gives AstraZeneca billion-dollar potential Behind the AstraZeneca advice is a recent FDA approval of the breast cancer treatment Etc…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Bank of America is looking at both pharmaceuticals and wind power. The bank issues buy recommendations for AstraZeneca and Nordex, citing valuations that are considered too attractive to ignore. The cases differ, but the conclusion is the same: Bank of America sees a buy position in both companies. FDA announcement gives AstraZeneca billion-dollar potential Behind the AstraZeneca advice is a recent FDA approval of the breast cancer treatment Etc…